Global Blood Therapeutics Stock Technical Analysis

GBTDelisted Stock  USD 68.49  0.00  0.00%   
As of the 28th of March, Global Blood retains the Risk Adjusted Performance of 0.1164, coefficient of variation of 517.98, and Market Risk Adjusted Performance of 0.8829. Global Blood technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We have analyzed eighteen technical drivers for Global Blood Therapeutics, which can be compared to its competitors. Please check out Global Blood Therapeutics variance, value at risk, as well as the relationship between the Value At Risk and skewness to decide if Global Blood is priced fairly, providing market reflects its last-minute price of 68.49 per share. Given that Global Blood Therapeutics has treynor ratio of 0.8729, we strongly advise you to confirm Global Blood Therapeutics's regular market performance to make sure the company can sustain itself at a future point.

Global Blood Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Global, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Global
  
Global Blood's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Global Blood technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Global Blood technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Global Blood trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Global Blood Therapeutics Technical Analysis

Indicator
Time Period
Execute Indicator
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.

Global Blood Therapeutics Trend Analysis

Use this graph to draw trend lines for Global Blood Therapeutics. You can use it to identify possible trend reversals for Global Blood as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Global Blood price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Global Blood Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Global Blood Therapeutics applied against its price change over selected period. The best fit line has a slop of   0.67  , which may imply that Global Blood Therapeutics will maintain its good market sentiment and make money for investors. It has 122 observation points and a regression sum of squares at 16809.22, which is the sum of squared deviations for the predicted Global Blood price change compared to its average price change.

About Global Blood Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Global Blood Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Global Blood Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Global Blood Therapeutics price pattern first instead of the macroeconomic environment surrounding Global Blood Therapeutics. By analyzing Global Blood's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Global Blood's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Global Blood specific price patterns or momentum indicators. Please read more on our technical analysis page.

Global Blood March 28, 2024 Technical Indicators

Most technical analysis of Global help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Global from various momentum indicators to cycle indicators. When you analyze Global charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Note that the Global Blood Therapeutics information on this page should be used as a complementary analysis to other Global Blood's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Consideration for investing in Global Stock

If you are still planning to invest in Global Blood Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Global Blood's history and understand the potential risks before investing.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
CEOs Directory
Screen CEOs from public companies around the world
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Transaction History
View history of all your transactions and understand their impact on performance